Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study

Neisseria meningitidis is associated with high mortality and morbidity in infants and children worldwide. This phase 3 study (NCT02173704) evaluated safety and immunogenicity of a 4-component serogroup B recombinant meningococcal vaccine (4CMenB) co-administered with routine vaccines in Taiwanese in...

Full description

Bibliographic Details
Main Authors: Nan-Chang Chiu, Li-Min Huang, Arnold Willemsen, Chiranjiwi Bhusal, Ashwani Kumar Arora, Zenaida Reynoso Mojares, Daniela Toneatto
Format: Article
Language:English
Published: Taylor & Francis Group 2018-05-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
neisseria meningitidis
serogroup b meningococcal vaccine
immunogenicity
co-administration
safety
infant
Online Access:http://dx.doi.org/10.1080/21645515.2018.1425659

Internet

http://dx.doi.org/10.1080/21645515.2018.1425659

Similar Items